Abstract
Much has been written about the dire state of treatment development for mental disorders (1). While there has been progress in the development of devices and psychosocial treatments, psychopharmacology over the past decade appears to have stalled after four decades of exuberant growth (2).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have